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Introduction: Among the surgical procedures for treatment of morbid obesity, laparoscopic sleeve gas-
trectomy has known widespread diffusion in the last years, although it is not free from signiﬁcant
morbidity rates. Aim of this work is to evaluate the incidence of Helicobacter pylori (HP) infection on the
postoperative outcome of patients undergoing laparoscopic sleeve gastrectomy.
Methods: Between January 2008 and December 2013, 184 patients (65 males, 119 females), mean age
35.8 ± 5.7 years, affected with morbid obesity, mean BMI 46.6 ± 6.7, underwent laparoscopic sleeve
gastrectomy. All the specimens at the end of the operation were analysed by the same pathologist.
Histological grading was based on the Sidney classiﬁcation.
Results: Seventy-twoof the patients (39.1%)wereHPpositive,while 112 (60.9%)were negative.No signiﬁcant
differences were observed between the HPþ and HP group in terms of age, sex, weight, BMI, incidence of
comorbidities and duration of follow-up. All the operations were completed via laparoscopic approach. No
mortalitywas observed. Postoperative complicationsoccurred in5patients (2.7%): three leaks (1.6%), all in the
HP- group and two bleedings (1.1%), one in the HPþ and one in the HP group. In two cases a reintervention
was necessary. No signiﬁcant differences were observed in the morbidity rates between the two groups.
Overall mean excess weight loss at 6 months, 12 months and 24 months was respectively 47.4 ± 11.3%,
61.1 ± 12.4% and 68.4 ± 13.5%, with no signiﬁcant differences between the HPþ and HP groups.
Conclusions: HP infection seems not to inﬂuence postoperative outcome of patients operated of lapa-
roscopic sleeve gastrectomy.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Helicobacter pylori, for the ﬁrst time described by Warren and
Marshall in 1984 [1], has been object of many trials who clariﬁed its
role in the pathogenesis of peptic ulcer disease and gastric cancer,
while contradictory results emerged from different epidemiologic
studies who tried to evaluate its correlation with morbid obesity
[2e6]. In the last 20 years laparoscopic bariatric surgery has known
widespread diffusion for its excellent results in terms of excess
weight loss and resolution of comorbidities [7,8]. Among theetti).
by Elsevier Ltd. All rights reserveddifferent surgical procedures, laparoscopic sleeve gastrectomy
(LSG) is becoming a popular restrictive procedure as it is effective in
achieving 60e70% excess weight loss at a medium term follow up
[9,10], although it is not free from signiﬁcant complications rates
[11e13]. Aim of this work is to evaluate the role of Helicobacter
pylori (HP) infection on the postoperative outcome of patients
undergoing laparoscopic sleeve gastrectomy.2. Methods
Between January 2008 and December 2013, patients affected
with morbid obesity came to our observation and were included in
the study. Inclusion criteria were a body mass index greater than.
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comorbidities, failed medical treatment of >5 years, and age 18e60
years. Exclusion criteria were contraindications to laparoscopic
surgery, a second bariatric operation, previous gastric surgery, giant
hiatal hernia, severe gastroesophageal reﬂux disease, pregnancy,
psychiatric disease, and BMI >60 kg/m2. Patients were addressed to
LSG after a multidisciplinary team evaluation including a surgical,
psychiatric, nutritional and endocrinological visit. Preoperative
examinations included complete blood laboratory examens, elec-
trocardiogram and cardiologic visit, chest x-ray and pulmonary
function test, upper endoscopy and abdominal ultrasound.
Informed consent was obtained before the operation. Primary end-
point were early and late complications, while secondary end-point
was excess weight loss (EWL). Early complications were those
occurring during the ﬁrst 30 postoperative days, and late compli-
cations were later on.3. Surgical technique
As previously described [13], the operation was conducted via
laparoscopic approach. After pneumoperitoneum induction at a
15 mmHg value by a Veress needle, ﬁve trocars were introduced.
Dissection of gastric greater curvature started at 3 cm from the
pylorus and was conducted upwards until the angle of His by
means of Ligasure (Covidien, Mansﬁeld, MA). Resection of the
stomach was performed by Echelon 60 Endopath (Ethicon Endo-
Surgery, Cincinnati, OH) with green and gold cartridges, under a
36-Fr calibration bougie. Once the gastric partition had been
completed, an upper endoscopy was performed to check the
integrity of the suture line. Resected stomach was extracted from
the abdominal cavity through a dilated 12-mm trocar incision in a
specimen bag. At the end of operation, a drainwas placed alongside
the staple line: it was removed generally on 5th postoperative day
after performing an upper GI X-ray. The patients were discharged
home on the 6th postoperative daywith prescription of a 40mg per
day oral PPI therapy for six months. Liquid diet started on 6th
postoperative day and was allowed for 10e15 days under strict
nutritionist surveillance.4. Specimens evaluation
All the sleeve gastrectomy specimens were analysed by the
same pathologist who was unaware of clinical information. Biopsy
specimens were ﬁxed in 10% formalin and embedded in parafﬁn.
The sections were subsequently stained with ematoxylin and eosin.
Giemsa staining was used to detect the existence of HP. Histological
grading was based on the Sidney classiﬁcation [14]. Accordingly,
the following histopathologic variables were examined on each
case: Helicobacter pylori density, polymorphonuclear neutrophil
activity, degree of chronic inﬂammation, degree of glandular atro-
phy, presence of intestinal metaplasia. Each variable was graded asTable 1
Demographic and anthropometric data.





Age (years) (range) 35.8 ± 5.7 (19e59) 32.4
Weight (Kg) (range) 130.8 ± 19.3 (90e180) 124
BMI (Kg/m2) (range) 46.6 ± 6.7 (37.5e59.1) 44.4
Hypertension 57 (31.0%) 20
Diabetes 48 (26.1%) 19
Sleep apnea 18 (9.8%) 6 (8
Follow-up (months) (range) 27.6 ± 6.8 (3e74) 26.5mild, moderate or severe using Dixon et al. visual analogue scale
[14]. Helicobacter pylori density was grade as none, mild when few
microorganism were present, moderate when bacteria were pre-
sent in separate foci and severe when near complete or complete
surface layering with Helicobacter pylori was observed. Poly-
morphonuclear neutrophil activity was classiﬁed as none, mild
when up to two crypts were involved per biopsy, moderate when
up to 50% of crypts were involved and severe when more than 50%
of crypts were affected. Chronic inﬂammation was deﬁned as
gastric mucosa inﬁltration by both lymphocytes and plasma cells. It
was graded as none, mild when chronic inﬂammatory cells were
scattered, moderate when chronic inﬂammatory cells inﬁltrate
were diffuse and severe when chronic inﬂammatory cells were
diffuse and dense separating the gastric glands. Glandular atrophy
was scored as none, mild, moderate and severe using the visual
analogue score. Intestinal metaplasia was graded as none, mild
when one focus-up to four crypts- was replaced by intestinal type
epithelium, moderate when multiple foci were affected comprising
less than 50% of gastric epithelium, and severewhenmore than 50%
of gastric epithelium was replaced by intestinal metaplasia.5. Statistical analysis
Continuous demographic and anthropometric variables were
expressed as mean ± standard deviation. Correlation between
ordinal or continuous variables was performed using Spearman
rank correlation test. Comparisons between groups were made
using the Student t-test for continuous variables. The Pearson Х 2
contingency test was used to test the signiﬁcance of differences
between proportions and categorical variables. Histologic score of
gastritis was treated as ordinal variables. Spearman rank correla-
tions were used to test the correlation between histologic score of
gastritis and preoperative bodyweight data as well as percentage of
excess weight loss at different follow-up intervals. Independent
predictors of good and poor results were identiﬁed by multivariate
binary logistic regression. All analyses were two-tailed. A p-value
<0.05 was considered statistically signiﬁcant. The SPSS statistical
software (SPSS, Inc., Chicago, IL) was used for statistical analysis.6. Results
A total of 184 patients (65 males, 119 females) were enrolled.
Their mean age was 35.8 ± 5.7 years (range 19e59), mean BMI
46.6 ± 6.7 (range 37.5e59.1). Seventy-two of the patients (39.1%)
were HP positive, while 112 were negative (60.9%). Mean follow-up
was 27.6 ± 6.8 months (range 3e74). Demographic and preopera-
tive data are summarized in Table 1. No signiﬁcant differences were
observed between the HPþ and HP- group in terms of age, sex,
weight, BMI, incidence of comorbidities and duration of follow-up.
All the interventions were completed via laparoscopic approach. No






± 4.5 (19e57) 37.3 ± 5.2 (20e59) 0.123
.5 ± 17.2 (90e165) 132.6 ± 12.3 (95e180) 0.224
± 5.2 (38.6e59.1) 47.2 ± 4.3 (37.5e58.7) 0.346
(27.8%) 37 (33.0%) 0.233
(26.4%) 29 (25.9%) 0.678
.3%) 12 (10.7%) 0.455
± 5.4 (3e73) 28.1 ± 4.3 (4e74) 0.787
Table 2
Postoperative results.
All patients (n ¼ 184) HPþ (n ¼ 72) (39.1%) HP (n ¼ 112) (60.9%) P Value
Intraoperative blood loss (ml) (range) 45.3 ± 15.4 (30e150) 42.1 ± 12.3 (30e120) 46.4 ± 14.1 (40e150) 0.342
Operative time (min) (range) 64.4 ± 12.6 (55e125) 63.2 ± 11.4 (60e125) 65.6 ± 14.1 (55e120) 0.577
Overall morbidity 5 (2.7%) 1 (1.4%) 4 (3.6%) 0.09
Leak 3 (1.6%) 0 3 (2.7%) 0.067
Bleeding 2 (1.1%) 1 (1.4%) 1 (0.9%) 0.124
Hospital stay 6.4 ± 3.3 (5e25) 5.3 ± 2.4 (5e13) 6.5 ± 2.2 (5e25) 0.078
EWL 6 months (%) 47.4 ± 11.3 46.3 ± 12.9 48.5 ± 11.7 0.355
EWL 12 months (%) 61.1 ± 12.4 63.5 ± 14.2 60.1 ± 11.4 0.246
EWL 24 months (%) 68.4 ± 13.5 66.4 ± 14.1 69.3 ± 13.3 0.112
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55e125) while mean hospital stay was 6.4 ± 3.3 days (range 5e25)
with no signiﬁcant differences between the two groups (Table 2).
Overall morbidity was as following: three leaks (1.6%) occurred, all
in the HP group and two bleedings (1.1%), one in the HPþ and one
in the HP group. In two patients a reinterventionwas necessary, in
one case for the treatment of a leak occurred on the 3rd post-
operative day, repaired via laparoscopic approach by means of
direct suture and abdominal cavity drainage and in another case for
an emergency splenectomy for massive bleeding. In all the other
cases a conservative treatment was successful and no reoperation
was necessary. No signiﬁcant differences were observed in the
morbidity rates between the two groups (Table 2). Overall mean
EWL at 6 months, 12 months and 24 months was respectively
47.4 ± 11.3%, 61.1 ± 12.4% and 68.4 ± 13.5%, with no signiﬁcant
differences between the HPþ and HP groups (Table 2).7. Discussion
While different trials have investigated the correlation between
HP infection and morbid obesity with contradictory results [2e6], a
limited number of articles have been published dealing with the
inﬂuence of HP on postoperative outcome of laparoscopic bariatric
surgery. Wang et al. [15] investigated the role of HP on the outcome
of laparoscopic vertical banded gastroplasty: they observed no
correlation with morbidity incidence, while less excess weight loss
at 24 and 48 months was achieved in patients HPþ. Hartin Jr. et al.
[16] evaluated a series of patients operated of laparoscopic gastric
bypass: while no postoperative complication arised among the
patients tested and treated for HP in the preoperative assessment, a
perforation of gastrojejunal anastomosis occurred in 5% of patients
not tested. They concluded that preoperative HP screening should
be routinely performed in order to decrease the rate of post-
operative complications. This was the only study ﬁnding a positive
correlation between HP infection and postoperative complications
in bariatric surgery. Recently, other two studies [17,18] investigated
the role of HP on postoperative outcome of sleeve gastrectomy:
both concluded that HP infection has no impact on postoperative
morbidity rates. Even, another trial documented that LSG can bring,
as a consequence, to eradication of Helicobacter pylori infection:
Keren et al. [19], on a group of 40 patients operated of LSG,
observed HP infection in 17 cases (42.5%) in excluded stomach. At a
3-months follow-up, only three out of them (17.6%) were tested
positive for HP at urea breath test. Our results support the evi-
dences emerged from the literature as no correlation was docu-
mented between HP and occurrence of postoperative
complications: even, gastric leaks occurred only in patients HP (3/
112, 2.7% vs 0% in HPþ group) (p ¼ 0.067) (NS). Furthermore, at our
knowledge, our trial is the ﬁrst one to evaluate not only the impact
of HP infection on postoperative complications, but even on EWL of
LSG at a medium term follow-up: as it has been evidenced inTable 2, no differences were observed in terms of EWL between
HPþ and HP groups at 6, 12 and 24 months follow-up. In
conclusion, in our opinion, while routine upper endoscopy should
always be performed in the preoperative assessment of patients
candidate to bariatric surgery [20,21], eradication of HP infection
before undergoing intervention is not mandatory as it seems not to
have inﬂuence on outcome of patients operated for morbid obesity.
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